Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wellmune WGP, derived from a proprietary strain of yeast, reduces allergy symptoms and improves the quality of life of individuals who suffer from ragweed allergy, according to a study conducted by Biothera.
Subscribe to our email newsletter
The placebo-controlled, double-blinded study equally divided 48 healthy subjects (31 female, 17 male; 39 ± 13 years of age) into two groups.
One group consumed a placebo while the other a 250 mg serving of Wellmune WGP daily for four weeks during last September/October in an area of southeast Ohio where local pollen counts were high.
Individuals consuming Wellmune WGP demonstrated statistically significant reductions in overall allergy symptoms and severity.
Individuals also demonstrated reductions in key nasal and eye-related allergy symptoms and improvement on the Quality of Life Index, a scientifically validated tool for measuring how participants rate their overall sense of wellness.
Biothera Healthcare Research & Development senior vice president Don Cox said the new research shows that Wellmune also has the ability to modulate the immune system when less of a response is needed.